US 12,600,779

Application 18/515,530 · Granted Apr 14, 2026

Lag-3-binding molecules and methods of use thereof

Estimated expiration

June 7, 2036

9y 201d remaining

Confidence: high
High: no high-severity warning was raised, and any terminal disclaimer was resolved to the patents it references.
Earliest effective filing
Jun 7, 2016
+ 20 years
Jun 7, 2036
PTA +0d
Jun 7, 2036
TD applied
Jun 7, 2036
Final
Jun 7, 2036

This calculation includes patent term adjustment (PTA) under 35 U.S.C. §154(b). Patent term extension (PTE) under 35 U.S.C. §156 (for FDA-regulated products) is not included. Terminal disclaimers can affect PTA (In re Cellect, LLC).

Calculation details

Base term

Filing date
November 21, 2023
Earliest effective filing
June 7, 2016
Issue date
April 14, 2026
PTA
0 days
Base expiry (before PTA)
June 7, 2036

June 7, 2016 + 20 years = June 7, 2036

  • Continuation of application 17/147,279, filed Jan 12, 2021, issued as US 11,858,991
  • Continuation of application 15/580,029, filed Dec 6, 2017, issued as US 11,072,653
  • National stage entry of application PCTUS2016036172, filed Jun 7, 2016
  • National stage entry of application PCTUS2016036172, filed Jun 7, 2016
  • Continuation of application 15/580,029, filed Dec 6, 2017, issued as US 11,072,653
  • National stage entry of application PCTUS2016036172, filed Jun 7, 2016
  • PRO62/172,277 — Provisional — not used for base term
  • PRO62/255,094 — Provisional — not used for base term
  • PRO62/255,094 — Provisional — not used for base term
  • PRO62/172,277 — Provisional — not used for base term
  • PRO62/255,094 — Provisional — not used for base term
  • PRO62/172,277 — Provisional — not used for base term
  • PRO62/255,094 — Provisional — not used for base term
  • PRO62/172,277 — Provisional — not used for base term

Terminal disclaimers

TD approved1 approved, 1 filed

TD caps expiration to June 7, 2036

  • US 11,072,653· Application 15/580,029Capping patent

    Lag-3-binding molecules and methods of use thereof

    Filing date
    Dec 6, 2017
    Earliest effective filing
    Jun 7, 2016
    Issue date
    Jul 27, 2021
    PTA
    +51 days
    Calculated expiration
    Jul 28, 2036

    National stage entry of PCTUS2016036172, filed Jun 7, 2016

    Jun 7, 2016 + 20y + 51d PTA = Jul 28, 2036

  • US 11,858,991· Application 17/147,279

    Lag-3-binding molecules and methods of use thereof

    Filing date
    Jan 12, 2021
    Earliest effective filing
    Jun 7, 2016
    Issue date
    Jan 2, 2024
    PTA
    +314 days
    Calculated expiration
    Apr 17, 2037

    Continuation of 15/580,029, filed Dec 6, 2017, issued as US 11,072,653

    National stage entry of PCTUS2016036172, filed Jun 7, 2016

    National stage entry of PCTUS2016036172, filed Jun 7, 2016

    Jun 7, 2016 + 20y + 314d PTA = Apr 17, 2037

  • US 12,600,779· Application 18/515,530(from application 18/515,530)Capping patent

    Lag-3-binding molecules and methods of use thereof

    Filing date
    Nov 21, 2023
    Earliest effective filing
    Jun 7, 2016
    Issue date
    Apr 14, 2026
    PTA
    0 days
    Calculated expiration
    Jun 7, 2036

    Continuation of 17/147,279, filed Jan 12, 2021, issued as US 11,858,991

    Continuation of 15/580,029, filed Dec 6, 2017, issued as US 11,072,653

    National stage entry of PCTUS2016036172, filed Jun 7, 2016

    National stage entry of PCTUS2016036172, filed Jun 7, 2016

    Continuation of 15/580,029, filed Dec 6, 2017, issued as US 11,072,653

    National stage entry of PCTUS2016036172, filed Jun 7, 2016

    Jun 7, 2016 + 20y = Jun 7, 2036

Patent term extension under 35 U.S.C. §156, which can apply to certain drug, biologic, animal drug and medical device patents, is not included in this calculation. How PTE is calculated

You have the date. Your AI can have the file.

Application 18/515,530 · US 12,600,779

PatentReply compiles the prosecution history behind US 12,600,779: the claims as filed and as allowed, every Office Action and response, and the cited references, with each answer pointing back to the filed passage.

One new published application a month is free. The first compile takes a few minutes.

Strategy and filing changes require your approval.

How PatentReply handles an Office Action response →

Permanent link

www.patentreply.ai/tools/patent-expiration/US12600779

Data sourced from public USPTO records. This tool provides informational estimates and should not be relied upon as legal advice. Always verify patent expiration dates independently, especially where patent term extension, terminal disclaimers, or unusual continuity issues may apply.